Stephen Friscia

Insider Reports History

Location
855 N. Wolfe Street, Suite 623, Baltimore, MD
Signature
/s/ Stephen Friscia
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Friscia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TNF Pharmaceuticals, Inc. Director Common stock 2.16K $194 $0.09 Oct 3, 2025 Direct

Insider Reports Filed by Stephen Friscia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QCLS Q/C TECHNOLOGIES, INC. Oct 3, 2025 1 $0 4 Oct 6, 2025 Director
MYMD MyMD Pharmaceuticals, Inc. Jun 13, 2024 0 $0 3 Jun 28, 2024 Director